Carbiotix AB (publ) (NGM:CRBX)
5.74
+0.08 (1.41%)
At close: Nov 7, 2025
Carbiotix AB Company Description
Carbiotix AB (publ), a biotechnology company develops health testing and microbiome modulators to address a range of chronic and metabolic diseases.
Its portfolio includes prebiotic ingredients and diagnostic testing services. The company develops CarbiAXOS, a second-generation prebiotic soluble fiber based on virgin and upcycled natural substrates containing arabinoxylo-oligosaccharides that is customized to meet customer needs to the production of short chain fatty acids or any other effect; and LinkGut, a health test.
Carbiotix AB (publ) was incorporated in 2014 and is based in Lund, Sweden.
Carbiotix AB (publ)
| Country | Sweden |
| Founded | 2014 |
| Industry | Biological Products, Except Diagnostic Substances |
| Employees | 8 |
| CEO | Erik Deaner |
Contact Details
Address: ScheelevAegen 22 Lund, 223 63 Sweden | |
| Phone | 46 46 19 10 00 |
| Website | carbiotix.com |
Stock Details
| Ticker Symbol | CRBX |
| Exchange | Nordic Growth Market |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Erik Deaner | Chief Executive Officer |
| Henrik Ljung | Chief Financial Officer |